Using single cell technologies to understand HIV latency models
- PMID: 40742736
- PMCID: PMC12321199
- DOI: 10.1097/COH.0000000000000959
Using single cell technologies to understand HIV latency models
Abstract
Purpose of review: This review outlines current model systems of HIV latency and their analysis with single-cell omics technologies. Previous studies have used bulk analyses of infected cell cultures to determine mechanisms of HIV transcription and to identify targets associated with HIV latency in vitro . However, heterogeneity in cell populations creates a barrier to the effectiveness of latency reversing agents. Single cell approaches promise to accelerate our understanding of how the host cell environment regulates complex behaviors of the HIV provirus.
Recent findings: Several recent papers have applied cutting edge single cell omics methods to model systems of HIV latency, including scRNAseq and scATACseq, as well as multiomic methods such as DOGMAseq and ECCITEseq. These papers have revealed complex heterogeneity in latently infected cells but have also led to the identification of several new host cell genes that regulate HIV latency.
Summary: Single-cell technologies provide sensitive detection of cellular subpopulations that contribute to proviral reactivation and latency, making them advantageous to apply to widely used cell line and primary cell models of HIV latency. These studies have increased our understanding of HIV latency model systems and generated novel hypotheses which can be tested in clinical samples from people with HIV.
Keywords: HIV reservoir; cell lines; latency; primary cells; single cell multiomics.
Copyright © 2025 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
Conflict of interest
Nothing Declared
References
-
- Finzi D, Hermankova M, Pierson T, Carruth LM, Buck C, Chaisson RE, Quinn TC, Chadwick K, Margolick J, Brookmeyer R, Gallant J, Markowitz M, Ho DD, Richman DD, Siliciano RF. 1997. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 278:1295–1300. - PubMed
-
- Mbonye U, Karn J. 2017. The Molecular Basis for Human Immunodeficiency Virus Latency. Annu Rev Virol 4:261–285. - PubMed
-
- Mzingwane ML, Tiemessen CT. 2017. Mechanisms of HIV persistence in HIV reservoirs. Rev Med Virol 27. - PubMed
-
-
Saylor D, Dickens AM, Sacktor N, Haughey N, Slusher B, Pletnikov M, Mankowski JL, Brown A, Volsky DJ, McArthur JC. 2016. HIV-associated neurocognitive disorder--pathogenesis and prospects for treatment. Nat Rev Neurol 12:234–248.
* This paper reviews HIV-related neurocognitive disorders as well as outlines the latest data from studies trying to understand and treat disrupted neurocognitive functioning in people living with HIV.
-
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
